Thomas Holzmann
Impact in
- Endocrinology top 10%
- Diphtheria, Corynebacterium, and Tetanus
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
-
- COVID-19 Clinical Research Studies 4
- Infection Control in Healthcare 3
- Co-authors
- Bernhard Katzy (5 shared papers)Klaus Sailer (5 shared papers)Wulf Schneider‐Brachert (9 shared papers)Bernd Salzberger (8 shared papers)Florian Hitzenbichler (5 shared papers)Frank Hanses (4 shared papers)Bárbara Schmidt (2 shared papers)Felix Buder (2 shared papers)
- Journals
- Technology Analysis and Strategic Management (3 papers)Emerging infectious diseases (3 papers)Infection (2 papers)PLoS ONE (2 papers)Infectious Diseases (1 paper)
- Partner nations
- GermanyAustriaNetherlands
In The Last Decade
Thomas Holzmann
38 papers receiving 688 citations
Peers
Comparison fields: 5 of 148
- Endocrinology 54
- Infectious Diseases 176
- Management of Technology and Innovation 65
- Business and International Management 17
- Applied Microbiology and Biotechnology 15
Countries citing papers authored by Thomas Holzmann
This map shows the geographic impact of Thomas Holzmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Holzmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Holzmann more than expected).
Fields of papers citing papers by Thomas Holzmann
This network shows the impact of papers produced by Thomas Holzmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Holzmann. The network helps show where Thomas Holzmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Holzmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 128 | |
| 2 | 2013 | 107 | |
| 3 | 2012 | 46 | |
| 4 | 2014 | 43 | |
| 5 | 2013 | 37 | |
| 6 | 2021 | 36 | |
| 7 | 2013 | 34 | |
| 8 | 2011 | 30 | |
| 9 | 2017 | 25 | |
| 10 | 2018 | 24 | |
| 11 | 2014 | 21 | |
| 12 | 2012 | 20 | |
| 13 | 2018 | 20 | |
| 14 | 2012 | 20 | |
| 15 | 2021 | 14 | |
| 16 | 2012 | 12 | |
| 17 | 2021 | 11 | |
| 18 | 2021 | 10 | |
| 19 | Plane-based Surface Regularization for Urban 3D Reconstruction | 2017 | 9 |
| 20 | 2017 | 8 |
About Thomas Holzmann
Thomas Holzmann is a scholar working on Infectious Diseases, Epidemiology, Molecular Biology, Strategy and Management and Molecular Medicine, having authored 41 papers that have together received 714 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (5 papers), Bacillus and Francisella bacterial research (4 papers), Advanced Vision and Imaging (4 papers), Bacterial Identification and Susceptibility Testing (4 papers), COVID-19 Clinical Research Studies (4 papers), Remote Sensing and LiDAR Applications (3 papers), Innovative Approaches in Technology and Social Development (3 papers) and Infection Control in Healthcare (3 papers). The work is most often cited by research in Endocrinology (54 citations), Infectious Diseases (176 citations), Management of Technology and Innovation (65 citations), Business and International Management (17 citations) and Applied Microbiology and Biotechnology (15 citations). Thomas Holzmann has collaborated with scholars based in Germany, Austria and Netherlands. Frequent co-authors include Bernhard Katzy, Klaus Sailer, Wulf Schneider‐Brachert, Bernd Salzberger, Florian Hitzenbichler, Frank Hanses, Bárbara Schmidt, Felix Buder, Boris Ehrenstein and Benedikt Lampl. Their work appears in journals such as Technology Analysis and Strategic Management, Emerging infectious diseases, Infection, PLoS ONE and Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.